Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial?

(MedPage Today)-Parkinid’s Experience in the PD3 was unable to slow the weekly injection of GLP-1 receptors (byetta, Bydureon). In 96 weeks, a medium movement disorder community …